Adagene ADAG
NASDAQ ADAG
$3.58 -0.11 (-2.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Adagene (ADAG) Invested Capital (2019 - 2026)

Adagene (ADAG) posted quarterly Invested Capital of $711.4 billion for Q4 2025, down 94.5% year-over-year from $12923.6 billion in Q4 2024, and up 15668621.15% quarter-over-quarter from $4.5 million in Q2 2025.

Analysis

Adagene (ADAG) Invested Capital (2019 - 2026) Analysis & Trends

Adagene (ADAG) has reported Invested Capital for 7 consecutive years, with $711.4 billion the latest figure, recorded in Q4 2025.

  • In Q4 2025, Invested Capital fell 94.5% year-over-year to $711.4 billion; the TTM figure through Dec 2025 stood at $13635.0 billion (down 30.72% YoY), while the FY2025 annual figure was $711.4 billion, down 94.5% from the prior year.
  • Invested Capital climbed to $711.4 billion in Q4 2025 per ADAG's latest filing, from $4.5 million in the prior quarter.
  • Across five years, Invested Capital topped out at $12923.6 billion in Q4 2024 and bottomed at $358958.0 in Q4 2021.
  • Historically, Invested Capital has averaged $2459.4 billion across 5 years, with a median of $1031.8 billion in 2022.
  • Annual changes were most pronounced in 2022 — Invested Capital soared 794000312.3% — and 2024, when it plunged 100.0%.
  • Adagene's Invested Capital stood at $358958.0 in 2021, then jumped by 794000312.3% to $2850.1 billion in 2022, then soared by 46.01% to $4161.5 billion in 2023, then soared by 210.55% to $12923.6 billion in 2024, then sank by 94.5% to $711.4 billion in 2025.
  • Business Quant data shows ADAG's Invested Capital at $711.4 billion in Q4 2025, $4.5 million in Q2 2025, and $12923.6 billion in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 33.70 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 7.35 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 6.25 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.13 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.30 Bn
10 Adagene 211.24 Mn 211.24 Mn - 95.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 95.18 Mn
Dec 31, 2025 41.47 Mn
Jun 30, 2025 44.55 Mn
Dec 31, 2024 68.73 Mn
Jun 30, 2024 77.12 Mn
Dec 31, 2023 92.50 Mn
Jun 30, 2023 107.73 Mn
Dec 31, 2022 110.86 Mn
Jun 30, 2022 129.26 Mn
Dec 31, 2021 164.05 Mn
Jun 30, 2021 193.90 Mn
Dec 31, 2020 -81.41 Mn
Dec 31, 2019 -54.45 Mn